Compare $APVO vs $REVB | Chartloom

Compare

$APVO vs $REVB

Aptevo Therapeutics Inc · Revelation Biosciences Inc

APVO

Aptevo Therapeutics Inc

REVB

Revelation Biosciences Inc

Compare $APVO vs $REVB

Comparing Aptevo Therapeutics Inc and Revelation Biosciences Inc

APVOAptevo Therapeutics Inc

REVBRevelation Biosciences Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

REVBRevelation Biosciences Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.6%

52W performance

-87.1%

FCF yield

-317.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

REVB

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

REVB

Revelation Biosciences Inc

Market Cap

APVO$2M

REVB$3M

Enterprise Value

APVO$-8M

REVB$-9M

Price

APVO$1.79

REVB$0.76

P/E Ratio

APVON/A

REVBN/A

P/S Ratio

APVO0.25x

REVB0.00x

EV/Sales

APVO-0.51x

REVB0.00x

EV/EBITDA

APVO-0.91x

REVB0.00x

P/B Ratio

APVO0.53x

REVB0.30x

P/FCF Ratio

APVON/A

REVBN/A

EV/FCF

APVO0.30x

REVB0.90x

PEG Ratio

APVON/A

REVBN/A

Forward P/E (NTM)

APVON/A

REVBN/A

Forward P/S (NTM)

APVON/A

REVBN/A

Revenue (TTM)

APVO$0

REVB$0

Revenue Growth (YoY)

APVON/A

REVBN/A

Forward Rev Growth

APVO206.8%

REVB115.3%

Gross Margin (TTM)

APVO51.4%

REVB0.0%

Operating Margin (TTM)

APVO0.0%

REVB0.0%

EBITDA Margin (TTM)

APVO0.0%

REVB0.0%

Net Margin (TTM)

APVO0.0%

REVB0.0%

FCF Margin (TTM)

APVON/A

REVBN/A

Net Income (TTM)

APVO$-28M

REVB$-19M

FCF (TTM)

APVO$-25M

REVB$-9M

EPS (TTM)

APVO-$23.47

REVB-$5.01

ROE (TTM)

APVO-20149.0%

REVB-10020.0%

ROA (TTM)

APVO-11921.0%

REVB-8273.0%

ROIC (TTM)

APVO-20149.0%

REVB-10020.0%

Cash

APVO$10M

REVB$11M

Debt

APVO$0

REVB$0

Net Cash/Debt

APVO$10M

REVB$11M

Current Ratio (TTM)

APVO2.08x

REVB6.21x

Quick Ratio (TTM)

APVO1.98x

REVB6.11x

Debt/Equity (TTM)

APVO0.00x

REVB0.00x

Debt/Assets (TTM)

APVO0.0%

REVB0.0%

Interest Coverage (TTM)

APVON/A

REVBN/A

Net Debt/EBITDA (TTM)

APVO0.00x

REVB0.00x

Beta

APVO1.68

REVB-0.14

52W Performance

APVO-94.2%

REVB-87.1%

YTD Performance

APVO-80.9%

REVB-76.6%

% from 52W High

APVO-94.6%

REVB-87.8%

% from 52W Low

APVO30.7%

REVB1.3%

Asset Turnover (TTM)

APVO0.22x

REVB0.00x

FCF Yield (TTM)

APVO-1132.6%

REVB-317.7%

Earnings Yield (TTM)

APVO-1254.8%

REVB-646.3%

Dividend Yield (TTM)

APVON/A

REVBN/A

Rule of 40

APVO0.0

REVB0.0

EV/GP/RG

APVON/A

REVBN/A

Ticker research

View APVO research View REVB research

Metric	APVO Aptevo Therapeutics Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$-9M
Price	$1.79	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.00x
EV/Sales	-0.51x	0.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	115.3%
Profitability
Gross Margin (TTM)	51.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-28M	$-19M
FCF (TTM)	$-25M	$-9M
EPS (TTM)	-$23.47	-$5.01
ROE (TTM)	-20149.0%	-10020.0%
ROA (TTM)	-11921.0%	-8273.0%
ROIC (TTM)	-20149.0%	-10020.0%
Financial Health
Cash	$10M	$11M
Debt	$0	$0
Net Cash/Debt	$10M	$11M
Current Ratio (TTM)	2.08x	6.21x
Quick Ratio (TTM)	1.98x	6.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	-0.14
52W Performance	-94.2%	-87.1%
YTD Performance	-80.9%	-76.6%
% from 52W High	-94.6%	-87.8%
% from 52W Low	30.7%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.00x
FCF Yield (TTM)	-1132.6%	-317.7%
Earnings Yield (TTM)	-1254.8%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View REVB research

Valuation

P/S Ratio

REVB

0.00x

APVO

0.25x

EV/FCF

APVO

0.30x

REVB

0.90x

Growth & revenue

Forward Revenue Growth

APVO

206.8%

REVB

115.3%

Profitability & performance

Gross Margin

APVO

51.4%

REVB

0.0%

ROE

REVB

-10020.0%

APVO

-20149.0%

FCF Yield %

REVB

-317.7%

APVO

-1132.6%

52-Week Performance

REVB

-87.1%

APVO

-94.2%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

REVB

Revelation Biosciences Inc

Market Cap

APVO$2M

REVB$3M

Enterprise Value

APVO$-8M

REVB$-9M

Price

APVO$1.79

REVB$0.76

P/E Ratio

APVON/A

REVBN/A

P/S Ratio

APVO0.25x

REVB0.00x

EV/Sales

APVO-0.51x

REVB0.00x

EV/EBITDA

APVO-0.91x

REVB0.00x

P/B Ratio

APVO0.53x

REVB0.30x

P/FCF Ratio

APVON/A

REVBN/A

EV/FCF

APVO0.30x

REVB0.90x

PEG Ratio

APVON/A

REVBN/A

Forward P/E (NTM)

APVON/A

REVBN/A

Forward P/S (NTM)

APVON/A

REVBN/A

Revenue (TTM)

APVO$0

REVB$0

Revenue Growth (YoY)

APVON/A

REVBN/A

Forward Rev Growth

APVO206.8%

REVB115.3%

Gross Margin (TTM)

APVO51.4%

REVB0.0%

Operating Margin (TTM)

APVO0.0%

REVB0.0%

EBITDA Margin (TTM)

APVO0.0%

REVB0.0%

Net Margin (TTM)

APVO0.0%

REVB0.0%

FCF Margin (TTM)

APVON/A

REVBN/A

Net Income (TTM)

APVO$-28M

REVB$-19M

FCF (TTM)

APVO$-25M

REVB$-9M

EPS (TTM)

APVO-$23.47

REVB-$5.01

ROE (TTM)

APVO-20149.0%

REVB-10020.0%

ROA (TTM)

APVO-11921.0%

REVB-8273.0%

ROIC (TTM)

APVO-20149.0%

REVB-10020.0%

Cash

APVO$10M

REVB$11M

Debt

APVO$0

REVB$0

Net Cash/Debt

APVO$10M

REVB$11M

Current Ratio (TTM)

APVO2.08x

REVB6.21x

Quick Ratio (TTM)

APVO1.98x

REVB6.11x

Debt/Equity (TTM)

APVO0.00x

REVB0.00x

Debt/Assets (TTM)

APVO0.0%

REVB0.0%

Interest Coverage (TTM)

APVON/A

REVBN/A

Net Debt/EBITDA (TTM)

APVO0.00x

REVB0.00x

Beta

APVO1.68

REVB-0.14

52W Performance

APVO-94.2%

REVB-87.1%

YTD Performance

APVO-80.9%

REVB-76.6%

% from 52W High

APVO-94.6%

REVB-87.8%

% from 52W Low

APVO30.7%

REVB1.3%

Asset Turnover (TTM)

APVO0.22x

REVB0.00x

FCF Yield (TTM)

APVO-1132.6%

REVB-317.7%

Earnings Yield (TTM)

APVO-1254.8%

REVB-646.3%

Dividend Yield (TTM)

APVON/A

REVBN/A

Rule of 40

APVO0.0

REVB0.0

EV/GP/RG

APVON/A

REVBN/A

Ticker research

View APVO research View REVB research

Metric	APVO Aptevo Therapeutics Inc	REVB Revelation Biosciences Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$-9M
Price	$1.79	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.00x
EV/Sales	-0.51x	0.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.30x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	0.90x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	115.3%
Profitability
Gross Margin (TTM)	51.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-28M	$-19M
FCF (TTM)	$-25M	$-9M
EPS (TTM)	-$23.47	-$5.01
ROE (TTM)	-20149.0%	-10020.0%
ROA (TTM)	-11921.0%	-8273.0%
ROIC (TTM)	-20149.0%	-10020.0%
Financial Health
Cash	$10M	$11M
Debt	$0	$0
Net Cash/Debt	$10M	$11M
Current Ratio (TTM)	2.08x	6.21x
Quick Ratio (TTM)	1.98x	6.11x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	-0.14
52W Performance	-94.2%	-87.1%
YTD Performance	-80.9%	-76.6%
% from 52W High	-94.6%	-87.8%
% from 52W Low	30.7%	1.3%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.00x
FCF Yield (TTM)	-1132.6%	-317.7%
Earnings Yield (TTM)	-1254.8%	-646.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View REVB research